Back to search

Article

Allosteric MAPKAPK2 Inhibitors Improve Plaque Stability in Advanced Atherosclerosis

2021-01-12

Abstract excerpt

<h4>ABSTRACT</h4> Atherosclerotic vascular disease resulting from unstable plaques is the leading cause of morbidity and mortality in subjects with type 2 diabetes (T2D), and thus a major therapeutic goal is to discover T2D drugs that can also promote atherosclerotic plaque stability. Genetic or pharmacologic inhibition of mitogen-activated protein kinase-activated protein kinase-2 (MK2) in obese mice improves gl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c6cf19d9-4a31-5336-abe2-d95d19e26cee
DOI
10.1101/2021.01.12.426264
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Allosteric MAPKAPK2 Inhibitors Improve Plaque Stability in Advanced AtherosclerosisDOI 10.1101/2021.01.12.426264
Select a neighboring publication to make it the new centre.